Along this line of reasoning, Huang et al. [75] importantly showed in an MLL-AF9-induced AML mouse model that blocking sEV secretion from ECs, but not perivascular cells, megakaryocytes, or spleen stromal cells, markedly delayed leukaemia progression. Here, MLLT3 is linked to acute myeloid leukemia.